Aarti Drugs Limited has submitted to the Exchange, the financial results for the period ended September 30, 2025.
AARTIDRUGS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Aarti Drugs Limited has filed its financial results with the exchange for the quarter and half-year ended September 30, 2025. The announcement is a routine compliance filing confirming submission of the results. No specific revenue, profit, or margin figures have been disclosed in this notice itself; investors would need to refer to the detailed results document for actual numbers. The filing meets the regulatory requirement under listing obligations for periodic financial disclosures.
No immediate price impact expected from this filing alone, as it is a standard submission notice. Shareholders should review the accompanying detailed results for any material changes in revenue, profitability, or outlook that could influence sentiment.